Press Releases Events & Presentations Event Details EASL 2018 Paris Apr 12, 2018 Supporting Materials EASL 2018, Paris, France, “Interim Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of ABI-H0731, a Novel Core Protein Allosteric Modifier (CpAM), in Healthy Volunteers and Non-Cirrhotic Viremic Subjects with Chronic Hepatitis B” 2 MB Shareholder Tools Print Email Alerts Printed Materials RSS News Feeds Search Investors
EASL 2018 Paris Apr 12, 2018 Supporting Materials EASL 2018, Paris, France, “Interim Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of ABI-H0731, a Novel Core Protein Allosteric Modifier (CpAM), in Healthy Volunteers and Non-Cirrhotic Viremic Subjects with Chronic Hepatitis B” 2 MB
EASL 2018, Paris, France, “Interim Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of ABI-H0731, a Novel Core Protein Allosteric Modifier (CpAM), in Healthy Volunteers and Non-Cirrhotic Viremic Subjects with Chronic Hepatitis B” 2 MB
